|
Prevalence
and Predictive Value of Intermittent Viremia With Combination HIV
Therapy [Havlir DV, et al. JAMA 2001; 286: 171]
posted 7/17/2001
HIV-1
Drug Resistance Profiles in Children and Adults With Viral Load
of < 50 Copies/mL Receiving Combination Therapy [Hemankova
M, et al. JAMA 2001; 286: 196]
posted 7/17/2001
Resource
Needs for HIV/AIDS [Schwartlander B et al. Science
2001; 292: 2434]
posted 7/17/2001
HIV-1
group O infection in Cameroon, 1986-1998 [Ayouba A, et al.
Emerg Infect Dis 2001;7:466]
posted 7/12/2001
Annan
calls for action on AIDS at UN meeting [McLellan F. Lancet
2001;357:2107]
posted 7/12/2001
A
meta-analysis of salvage therapy for Pneumocystis carinii
pneumonia [Smego RA, et al. Arch Intern Med 2001;161:1529]
posted 7/12/2001
Swiss
HIV Cohort Study [Geene D, Sudre P, Anwar D, et al. J
Infect 2000 Mar;40(2):160-3]
posted 7/10/2001
Updated
U.S. Public Health Service Guidelines for the Management of Occupational
Exposures to HVB, HCV and HIV and Recommendations for Postexposure
Prophylaxis [MMWR 2001; 50: RR-11]
posted 7/6/2001
Travel
and the introduction of human immunodeficiency virus type 1 non-B
subtype genetic forms into western countries [Thompson MM
and N'jera R. CID 2001;32:1731]
posted 7/6/2001
Nutrition
in the era of highly active antiretroviral therapy [Shevitz
AH and Knox TA. CID 2001;32:1769]
posted 7/6/2001
Uganda
launches HIV/AIDS treatment and training center for Africa
[Wendo C. Lancet 2001;357:1957]
posted 7/6/2001
Azithromycin
Approved by FDA for Disseminated MAC
posted 7/6/2001
The
Effect of Nevirapine in Combination With Nelfinavir in Heavily Pretreated
HIV-1-Infected Patients [Jensen-Fangel S et al. JAIDS
2001; 27: 124]
posted 7/3/2001
Hospitalization
Rates in an Urban Cohort After the Introduction of Highly Active
Antiretroviral Therapy [Gebo KA et al. JAIDS 2001;
27: 143]
posted 7/3/2001
Effect
of Ritonavir/Saquinavir on Stereoselection Pharmacokinetics of Methadone:
Results of AIDS Clinical Trials Group (ACTG) 401 [Gerber
JG et al. JAIDS 2001; 27: 153]
posted 7/3/2001
Incidence
and Determinants of Bacterial Infections in HIV-Positive Patients
Receiving Anti-Pneumocystis carinii/Toxoplasma gondii Primary
Prophylaxis Within a Randomized Clinical Trial [Wenger NS
et al. JAMA 2001; 285: 2880]
posted 7/3/2001
Relation
Between CD4 Cell Counts and HIV RNA Levels at Onset of Opportunistic
Infections [Brambilla AM et al. JAIDS 2001; 27: 44]
posted 7/3/2001
Pulmonary
Infiltrates in HIV-Infected Patients in the Highly Active Antiretroviral
Therapy Era in Spain [Benito N et al. JAIDS 2001;
27: 35]
posted 7/3/2001
Emergency
Department Management of Occupational Exposures: Cost Analysis of
Rapid HIV Test [Kallenborn JC et al. Infect Control Hosp
Epidemiol 2001; 22: 289]
posted 7/3/2001
|
archive